It is worth emphasizing that the tendency to reduce BAX expression in the MetS group may result from the impairment of the BCL-2 family pathway and the imbalance of pro- and antiapoptotic factors at the gene level, which may be caused by MS itself. This evidence concerns the gene BCL2 and myeloid sarcoma.